RESLIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG4
Sequence Origin	HUMANIZED RAT
Sequence Type	UNKNOWN
Record UNII	35A26E427H
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

RESLIZUMAB

Official Name

English

MAB HUMAN (IGG4) ANTI P05113 (IL5_HUMAN) (SCH55700)

Common Name

English

reslizumab [INN]

Common Name

English

Immunoglobulin G4, anti-(human interleukin 5) (human-rat monoclonal SCH 55700 γ4-chain), disulfide with human-rat monoclonal SCH 55700 light chain, dimer

Common Name

English

RESLIZUMAB [MI]

Common Name

English

Showing 1 to 5 of 14 entries

Previous1 2 3Next

Show entries

Classification Tree

Code System

Code

Designated

FDA ORPHAN DRUG

328510

Designated

FDA ORPHAN DRUG

237507

Established Pharmacologic Class

NDF-RT

N0000191872

Other systemic drugs for obstructive airway diseases

WHO-ATC

R03DX08

Biological Agent

NCI_THESAURUS

C20401

Showing 1 to 5 of 6 entries

Previous1 2Next

Show entries

Code System

Code

Type

Description

NCI_THESAURUS

C152197

PRIMARY

USAN

LL-65

PRIMARY

DRUG CENTRAL

5093

PRIMARY

DRUG BANK

DB06602

PRIMARY

INN

8106

PRIMARY

Showing 1 to 5 of 16 entries

Previous1 2 3 4Next

Subunit 0

Subunit 1

Subunit 2

Subunit 3

Show entries

From	To
1_22	1_95
2_22	2_95
2_130	4_214
2_143	2_199
2_257	2_317

Showing 1 to 5 of 16 entries

Previous1 2 3 4Next

Glycosylation Type

MAMMALIAN

Show entries

Showing 1 to 2 of 2 entries

Show entries

Related Record

Type

Details


					35A26E427H

ACTIVE MOIETY

Amount:

Showing 1 to 1 of 1 entries

Show entries

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:ESTIMATE	CHEMICAL	ESTIMATE 145000 Da (average)
Molecular Formula	CHEMICAL	ESTIMATED

Showing 1 to 2 of 2 entries